Kochar D K, Sharma B V, Gupta S, Jain R, Gauri L A, Srivastava T
Department of Medicine, SP Medical College, Bikaner (Rajasthan).
J Assoc Physicians India. 2003 Jan;51:33-6.
Pulmonary manifestations of Brucellosis are rare. We came across seven patients with predominant symptomatology of pulmonary involvement amongst 98 patients of active brucellosis seen in last four years.
The study is related to patients of brucellosis whose principal presenting features were related to respiratory symptom (cough, expectoration, pain in chest and breathlessness) along with fever and other constitutional symptoms. It included seven patients amongst 98 patients of active brucellosis seen during June 1996 to Feb. 2000 at PBM Hospital Bikaner. Diagnosis was confirmed by demonstration of the raised brucella agglutination titre of 1:320 or more in the serum. All patients were treated with rifampicin 900 mg daily and doxycyclin 100 mg twice daily for six week. The treatment was extended for another four weeks in two patients because of persistence of skiagram abnormalities.
Three patients had abnormality in skiagram chest in the form of pleural effusion, multiple paranchymal opacities and pneumonia. The skiagram chest was normal in remaining four patients. The response of treatment started with 10-15 days and all the patients became symptom-free at the end of six weeks except one patient. Skiagram chest at this time was normal in patients of pleural effusion but there was persistence of haziness and few opacities in other two patients. Follow up skiagram chest at the end of six months and twelve months was normal in all patients except calcified opacity in one patient. There was no evidence of relapse in any patient at the end of one year follow up. Liver function tests remained within normal range and no drug toxicity was observed.
Pulmonary manifestations of brucellosis are rare. Treatment with rifampicin and doxycylin showed marked clinical and radiological improvement. All patients were completely disease-free at the end of one year follow up.
布鲁氏菌病的肺部表现较为罕见。在过去四年中诊治的98例活动性布鲁氏菌病患者中,我们遇到了7例以肺部受累为主要症状的患者。
本研究涉及以呼吸道症状(咳嗽、咳痰、胸痛和呼吸困难)为主,伴有发热及其他全身症状的布鲁氏菌病患者。研究对象包括1996年6月至2000年2月在比卡内尔PBM医院诊治的98例活动性布鲁氏菌病患者中的7例。血清中布鲁氏菌凝集效价升高至1:320或更高可确诊。所有患者接受利福平每日900mg和多西环素每日100mg,分两次服用,疗程六周。由于胸片异常持续存在,两名患者的治疗延长了四周。
3例患者胸片异常,表现为胸腔积液、多发实质阴影和肺炎。其余4例患者胸片正常。治疗反应在10 - 15天开始显现,除1例患者外,所有患者在六周结束时症状消失。此时胸腔积液患者的胸片正常,但另外两名患者仍有模糊阴影和少量阴影。除1例患者有钙化阴影外,所有患者在六个月和十二个月结束时的随访胸片均正常。在一年的随访结束时,没有任何患者出现复发迹象。肝功能检查保持在正常范围内,未观察到药物毒性。
布鲁氏菌病的肺部表现罕见。利福平和多西环素治疗显示出明显的临床和影像学改善。在一年的随访结束时,所有患者均完全无病。